Envista
Daniel Raskas is SVP, Corporate Development of Danaher and co-leads mergers and acquisitions (M&A). He oversees investment activity, including identification, valuation, due diligence, contract strategy, and negotiations.
Daniel joined Danaher in 2004, originally serving as VP, Corporate Development, and was promoted to his current role in 2010. Throughout his tenure, he has led business development across the company and overseen a number of major acquisitions, including Beckman Coulter and Pall.
Before joining Danaher, Daniel was a partner at Thayer Capital Partners, a private equity firm focused on buyout and growth equity investments in the middle market. He also served as an associate at Arnold & Porter LLP for several years, where he specialized in transactional work including M&A and public offerings.
Daniel received a BA in Government from Harvard College, an MBA from Columbia University School of International and Public Affairs, and a JD from Harvard Law School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Envista
7 followers
Envista Holdings Corporation is a dental products company. The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.